Suzuki Y, Matsunaga N, Aoyama T, Ogami C, Hasegawa C, Iida S, To H, Kitahara T, Tsuji Y. Population pharmacokinetic analysis identifies an absorption process model for mycophenolic acid in patients with renal transplant. Clin Transl Sci. 2025. in press
Hirai T, Aoyama T, Tsuji Y, Ino K, Ikejiri M, Tawara I, Iwamoto T. Pharmacokinetic Model of Drug Interaction of Tacrolimus with Combined Administration of CYP3A4 Inhibitors Voriconazole and Clarithromycin After Bone Marrow Transplantation. Eur J Drug Metab Pharmacokinet. 2024. 49. 6. 763-771
Hirai T, Aoyama T, Tsuji Y, Itoh T, Matsumoto Y, Iwamoto T. Kinetic-pharmacodynamic model of warfarin for prothrombin time-international normalized ratio in Japanese patients. Br J Clin Pharmacol. 2024. 90. 3. 828-836
Tamura M, Murata S, Ota C, Tanaka S, Arichika H, Hakuno D, Okada N, Ushijima K, Tsuji Y, Kitahara T. Relationship between prolonged gestation and nifedipine pharmacokinetics in long-term tocolysis. Basic Clin Pharmacol Toxicol. 2024. 134. 2. 241-249
Ono R, Ogami C, Hasegawa C, To H, Matsumoto Y, Tsuji Y. Comparison of the efficacy of anti-diabetic medications as add-on to metformin in type 2 diabetes mellitus from a real-world database. BMC Pharmacol Toxicol. 2023. 24. 1. 75
Watanabe H, Nagano N, Tsuji Y, Noto N, Ayusawa M, Morioka I. Challenges of pediatric pharmacotherapy: A narrative review of pharmacokinetics, pharmacodynamics, and pharmacogenetics. Eur J Clin Pharmacol. 2024. 80. 2. 203-221
Exploring best practices of the population pharmacokinetic modeling for antibody-drug conjugates - A simulation study
(15rd American Conference on Pharmacometrics (ACoP) 2024 2024)
日本TDM学会
, International Society of Pharmacometrics (ISoP)
, 日本薬剤学会
, 日本薬物動態学会
, JAPANESE SOCIETY OF CHEMOTHERAPY
, THE JAPANESE SOCIETY OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
, JAPANESE SOCIETY OF PHARMACEUTICAL HEALTH CARE AND SCIENCES
, THE PHARMACEUTICAL SOCIETY OF JAPAN
